Primary Local Therapy

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Neoadjuvant Darovasertib in Primary Uveal MelanomaNCT07015190IDEAYA BiosciencesPhase 3Recruiting2030-10Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.